Stay updated with breaking news from Strong Sales. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Prudential Financial, Inc. (NYSE:PRU) Q1 2024 Earnings Call Transcript May 1, 2024 Prudential Financial, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Ladies and gentlemen, thank you for standing by, and welcome to Prudential’s Quarterly Earnings Conference Call. At […]
(Reuters) -Pfizer lifted its annual profit forecast on Wednesday, and reported first-quarter results that topped Wall Street estimates on cost cuts, a smaller-than-feared drop in sales of its COVID antiviral treatment and strong sales of its pneumonia vaccine. Sales of cancer treatment Padcev, which Pfizer gained through its $43 billion deal for Seagen, also came in ahead of analysts' expectations. The Seagen deal, as well as its $4 billion cost-cutting plan, are a key part of Pfizer's post-COVID growth strategy.
Musk Wins China's Backing for Tesla's Driver-Assistance Service Tentative approval for the software feature follows Musk's surprise visit to Beijing and marks a crucial victory in his push to... -April 29, 2024 at 11:17 am EDT - MarketScreener
BHP, Samarco and Vale Submit $26 Billion Samarco Dam Indicative Settlement Proposal BHP Brasil said that together with Samarco and Vale it has submitted a nonbinding indicative settlement... -April 29, 2024 at 09:16 am EDT - MarketScreener
(Reuters) -AbbVie raised its annual profit forecast on Friday after strong sales of its immunology drug Skyrizi and cancer drug Imbruvica helped the company beat Wall Street estimates for the first quarter. The company now expects adjusted profit of between $11.13 and $11.33 per share for this year, compared with $10.97 to $11.17 estimated earlier. Analysts on average expect annual profit of $11.10 per share, according to LSEG data.